Histamine and Receptors in Neuroinflammation: Their Roles on neurodegenerative diseases.

Astrocytes Histamine Histamine receptor Microglia Neurodegenerative diseases Neuroinflammation

Journal

Behavioural brain research
ISSN: 1872-7549
Titre abrégé: Behav Brain Res
Pays: Netherlands
ID NLM: 8004872

Informations de publication

Date de publication:
22 Mar 2024
Historique:
received: 14 01 2024
revised: 17 03 2024
accepted: 18 03 2024
medline: 25 3 2024
pubmed: 25 3 2024
entrez: 24 3 2024
Statut: aheadofprint

Résumé

Histamine, an auto-reactive substance and mediator of inflammation, is synthesized from histidine through the action of histidine decarboxylase (HDC). It primarily acts on histamine receptors in the central nervous system (CNS). Increasing evidence suggests that histamine and its receptors play a crucial role in neuroinflammation, thereby modulating the pathology of neurodegenerative diseases. Recent studies have demonstrated that histamine regulates the phenotypic switching of microglia and astrocytes, inhibits the production of pro-inflammatory cytokines, and alleviates inflammatory responses. In the CNS, our research group has also found that histamine and its receptors are involved in regulating inflammatory responses and play a central role in ameliorating chronic neuroinflammation in neurodegenerative diseases. In this review, we will discuss the role of histamine and its receptors in neuroinflammation associated with neurodegenerative diseases, potentially providing a novel therapeutic target for the treatment of chronic neuroinflammation-related neurodegenerative diseases in clinical settings.

Identifiants

pubmed: 38522596
pii: S0166-4328(24)00120-7
doi: 10.1016/j.bbr.2024.114964
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

114964

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Auteurs

Zhenyu Zhou (Z)

Department of Pharmacology, College of Basic Medicine, Binzhou Medical University, Yantai, China.

Qi An (Q)

Department of Pharmacology, College of Basic Medicine, Binzhou Medical University, Yantai, China.

Wanying Zhang (W)

Department of Pharmacology, College of Basic Medicine, Binzhou Medical University, Yantai, China.

Yixin Li (Y)

Department of Pharmacology, College of Basic Medicine, Binzhou Medical University, Yantai, China.

Qihang Zhang (Q)

Department of Pharmacology, College of Basic Medicine, Binzhou Medical University, Yantai, China.

Haijing Yan (H)

Department of Pharmacology, College of Basic Medicine, Binzhou Medical University, Yantai, China. Electronic address: hjyan211@163.com.

Classifications MeSH